302 related articles for article (PubMed ID: 34086743)
21. A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.
Lebbink RJ; de Jong DC; Wolters F; Kruse EM; van Ham PM; Wiertz EJ; Nijhuis M
Sci Rep; 2017 Feb; 7():41968. PubMed ID: 28176813
[TBL] [Abstract][Full Text] [Related]
22. CRISPR Interference Efficiently Silences Latent and Lytic Viral Genes in Kaposi's Sarcoma-Associated Herpesvirus-Infected Cells.
Brackett K; Mungale A; Lopez-Isidro M; Proctor DA; Najarro G; Arias C
Viruses; 2021 Apr; 13(5):. PubMed ID: 33924938
[TBL] [Abstract][Full Text] [Related]
23. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR/Cas9.
Oh HS; Neuhausser WM; Eggan P; Angelova M; Kirchner R; Eggan KC; Knipe DM
Elife; 2019 Dec; 8():. PubMed ID: 31789594
[TBL] [Abstract][Full Text] [Related]
24. The Antagonism between the Murine Gammaherpesvirus Protein Kinase and Global Interferon Regulatory Factor 1 Expression Shapes the Establishment of Chronic Infection.
Jondle CN; Sylvester PA; Schmalzriedt DL; Njoya K; Tarakanova VL
J Virol; 2022 Oct; 96(20):e0126022. PubMed ID: 36169331
[TBL] [Abstract][Full Text] [Related]
25. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
26. Conserved Gammaherpesvirus Protein Kinase Counters the Antiviral Effects of Myeloid Cell-Specific STAT1 Expression To Promote the Establishment of Splenic B Cell Latency.
Sylvester PA; Jondle CN; Stoltz KP; Lanham J; Dittel BN; Tarakanova VL
J Virol; 2021 Aug; 95(17):e0085921. PubMed ID: 34132573
[TBL] [Abstract][Full Text] [Related]
27. Identification of murine gammaherpesvirus 68 miRNA-mRNA hybrids reveals miRNA target conservation among gammaherpesviruses including host translation and protein modification machinery.
Bullard WL; Kara M; Gay LA; Sethuraman S; Wang Y; Nirmalan S; Esemenli A; Feswick A; Hoffman BA; Renne R; Tibbetts SA
PLoS Pathog; 2019 Aug; 15(8):e1007843. PubMed ID: 31393953
[TBL] [Abstract][Full Text] [Related]
28. Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication.
Khanal S; Cao D; Zhang J; Zhang Y; Schank M; Dang X; Nguyen LNT; Wu XY; Jiang Y; Ning S; Zhao J; Wang L; Gazzar ME; Moorman JP; Yao ZQ
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146709
[TBL] [Abstract][Full Text] [Related]
29. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
30. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
Chen YC; Sheng J; Trang P; Liu F
Viruses; 2018 May; 10(6):. PubMed ID: 29844277
[TBL] [Abstract][Full Text] [Related]
31. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Gutierrez IV; Dayton J; Harger S; Rossetto CC
J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
[TBL] [Abstract][Full Text] [Related]
32. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.
Darcis G; Binda CS; Klaver B; Herrera-Carrillo E; Berkhout B; Das AT
Viruses; 2019 Mar; 11(3):. PubMed ID: 30871200
[TBL] [Abstract][Full Text] [Related]
33. Development of a Csy4-processed guide RNA delivery system with soybean-infecting virus ALSV for genome editing.
Luo Y; Na R; Nowak JS; Qiu Y; Lu QS; Yang C; Marsolais F; Tian L
BMC Plant Biol; 2021 Sep; 21(1):419. PubMed ID: 34517842
[TBL] [Abstract][Full Text] [Related]
34. A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives
Wang Y; Ungerleider N; Hoffman BA; Kara M; Farrell PJ; Flemington EK; Lee N; Tibbetts SA
mBio; 2022 Jun; 13(3):e0083622. PubMed ID: 35642944
[TBL] [Abstract][Full Text] [Related]
35. Establishment of cell lines latently infected with non-oncogenic murine gammaherpesvirus 76.
Hrabovská Z; Chalupková A; Cipková J; Mistríková J
Acta Virol; 2010; 54(4):287-91. PubMed ID: 21175252
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.
Liang Z; Qin Z; Riker AI; Xi Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9-Mediated Genome Editing in Epstein-Barr Virus-Transformed Lymphoblastoid B-Cell Lines.
Jiang S; Wang LW; Walsh MJ; Trudeau SJ; Gerdt C; Zhao B; Gewurz BE
Curr Protoc Mol Biol; 2018 Jan; 121():31.12.1-31.12.23. PubMed ID: 29337376
[TBL] [Abstract][Full Text] [Related]
38. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
39. A Gammaherpesvirus MicroRNA Targets EWSR1 (Ewing Sarcoma Breakpoint Region 1)
Wang Y; Feldman ER; Bullard WL; Tibbetts SA
mBio; 2019 Jul; 10(4):. PubMed ID: 31363027
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus Vectors Expressing Eight Multiplex Guide RNAs of CRISPR/Cas9 Efficiently Disrupted Diverse Hepatitis B Virus Gene Derived from Heterogeneous Patient.
Kato Y; Tabata H; Sato K; Nakamura M; Saito I; Nakanishi T
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
